Title : The BRCA1-Δ11q Alternative Splice Isoform Bypasses Germline Mutations and Promotes Therapeutic Resistance to PARP Inhibition and Cisplatin.

Pub. Date : 2016 May 1

PMID : 27197267






2 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 The BRCA1-Delta11q Alternative Splice Isoform Bypasses Germline Mutations and Promotes Therapeutic Resistance to PARP Inhibition and Cisplatin. Cisplatin BRCA1 DNA repair associated Homo sapiens
2 CRISPR/Cas9 gene editing as well as overexpression experiments revealed that the BRCA1-Delta11q protein was capable of promoting partial PARPi and cisplatin resistance relative to full-length BRCA1, both in vitro and in vivo Furthermore, spliceosome inhibitors reduced BRCA1-Delta11q levels and sensitized cells carrying exon 11 mutations to PARPi treatment. Cisplatin BRCA1 DNA repair associated Homo sapiens